Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer now displays Revision: v3.4.2 instead of v3.4.1.SummaryDifference0.1%

- Check20 days agoChange DetectedOnly a backend revision update is visible, changing from v3.4.0 to v3.4.1; no study records, content, or navigation were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe history page now includes a glossary toggle, color-coded change highlights (green for additions, red for deletions), and a new Revision: v3.4.0 label, with No FEAR Act Data added to the notes.SummaryDifference0.7%

- Check42 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4 in the page history; this is a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These changes do not affect the study history content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page shows a new site revision tag, updating from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.